by Pharmaguapa | Nov 12, 2020 | General, Patient centric, Social Media
Last week I read in an article that 72% of patients do not feel listened to by pharma. This is a very sorry state of affairs, but sadly does not surprise me. Whilst patients are the end users they are not seen as customers. Traditionally patients have not had a say...
by Pharmaguapa | Oct 10, 2020 | Autoimmune Disease, hashimoto's, Patient centric, Social Media
Today is world mental health day. I have been quite open about my own battles with mental health, a result of my Hashimoto’s. In fact I received the diagnosis for depression six months before they identified that it was actually a symptom of thyroid disease. ...
by Pharmaguapa | Sep 20, 2020 | Autoimmune Disease, hashimoto's, Patient centric, Social Media
I was on a call last week where I found myself giving input into a brand strategy not as strategy consultant but as a patient advocate. My day job is advising life science’s companies on how to engage with their customers using digital technology. This...
by Pharmaguapa | Jun 10, 2020 | Facebook, Patient centric, Social Media, Twitter
Why do we need to be social? More particularly why do we need to be on social media? As you may know I am a huge advocate for social media. It provided me a lifeline may years ago when I was terribly ill. There are a myriad of reasons why we need to be social and...
by Pharmaguapa | May 22, 2020 | Artificial Intelligence, General, Patient centric, Social Media
This year mental health week feels more relevant than ever. As people across the world face isolation and anxiety due to Covid-19 we are seeing a rise in mental health problems. I feel incredibly fortunate to be living in a beautiful rural Suffolk village, with a...
by Pharmaguapa | Nov 6, 2019 | Autoimmune Disease, Leadership, Patient centric
Those of you who follow me on Twitter will have seen that yesterday I attend the PM Society’s event on patient collaboration. I found it a well put together event with a good balance of presenters from all the main stakeholder groups (perhaps with the exception...
